Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

895 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Artificial Intelligence in Emergency Radiology: Where Are We Going?
Cellina M, Cè M, Irmici G, Ascenti V, Caloro E, Bianchi L, Pellegrino G, D'Amico N, Papa S, Carrafiello G. Cellina M, et al. Among authors: papa s. Diagnostics (Basel). 2022 Dec 19;12(12):3223. doi: 10.3390/diagnostics12123223. Diagnostics (Basel). 2022. PMID: 36553230 Free PMC article. Review.
Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future.
Cellina M, Cè M, Irmici G, Ascenti V, Khenkina N, Toto-Brocchi M, Martinenghi C, Papa S, Carrafiello G. Cellina M, et al. Among authors: papa s. Diagnostics (Basel). 2022 Oct 31;12(11):2644. doi: 10.3390/diagnostics12112644. Diagnostics (Basel). 2022. PMID: 36359485 Free PMC article. Review.
Radiomics and Artificial Intelligence in Renal Lesion Assessment.
Cellina M, Irmici G, Pepa GD, Ce M, Chiarpenello V, Alì M, Papa S, Carrafiello G. Cellina M, et al. Among authors: papa s. Crit Rev Oncog. 2024;29(2):65-75. doi: 10.1615/CritRevOncog.2023051084. Crit Rev Oncog. 2024. PMID: 38505882 Review.
Artificial Intelligence in Lung Cancer Imaging: From Data to Therapy.
Cellina M, De Padova G, Caldarelli N, Libri D, Cè M, Martinenghi C, Alì M, Papa S, Carrafiello G. Cellina M, et al. Among authors: papa s. Crit Rev Oncog. 2024;29(2):1-13. doi: 10.1615/CritRevOncog.2023050439. Crit Rev Oncog. 2024. PMID: 38505877 Review.
Lifileucel, an Autologous Tumor-infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors.
Schoenfeld AJ, Lee SM, Doger de Speville B, Gettinger SN, Hafliger S, Sukari A, Papa S, Rodriguez-Moreno JF, Graf Finckenstein F, Fiaz R, Catlett M, Chen G, Qi R, Masteller EL, Gontcharova V, He K. Schoenfeld AJ, et al. Among authors: papa s. Cancer Discov. 2024 Apr 2. doi: 10.1158/2159-8290.CD-23-1334. Online ahead of print. Cancer Discov. 2024. PMID: 38563600 Free article.
895 results